Ledger.Open graph →
SEC Form D · filed June 28, 2023

Pelage Pharmaceuticals, Inc

Offering
$16.7M
Sold
$16.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Heather E. Christofk · Los Angeles, CAExecWilliam E. Lowry · Los Angeles, CADirectorCathy E. Friedman · Los Angeles, CADirectorDaniel Gil · Los Angeles, CAExec · DirectorJim B. Graham · Austin, TXExec · DirectorIsaac D. Barchas · Austin, TXDirectorSara Lewis · Brooklyn, NYDirectorBryan Bedard · La Jolla, CAExecRoger A. Le Tissier · St Peter Port, Y7Exec · DirectorPeter Sheppeard · Toronto, Ontario, CanadaDirectorJohn C. Loveless · St Peter Port, Y7ExecJeremy J. Coller · St Peter Port, Y7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗